Predict your next investment

Venture Capital
vanguardventures.com

See what CB Insights has to offer

Investments

189

Portfolio Exits

50

Funds

8

About Vanguard Ventures

Vanguard Ventures is an early stage venture capital firm that helps entrepreneurs build technology and life science companies.

Vanguard Ventures Headquarter Location

560 S. Winchester Blvd. Suite 500

San Jose, California, 95128,

United States

650.321.2900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vanguard Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Vanguard Ventures in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Vanguard Ventures News

DFINE Adds $25M in Fresh Capital

Nov 8, 2011

DFINE Adds $25M in Fresh Capital November 8, 2011 DFINE Inc., a maker of minimally invasive radiofrequency targeted therapies for the treatment of vertebral pathologies, closed a $25 million. Investors include OrbiMed Advisors, Prospect Venture Partners, Split Rock Partners, BBT Fund/Apothecary Capital, Highland Capital Management and Vanguard Ventures. PRESS RELEASE DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today the closing of a $25 million round of equity financing. The financing included current investors OrbiMed Advisors, Prospect Venture Partners, Split Rock Partners, BBT Fund/Apothecary Capital, Highland Capital Management, and Vanguard Ventures, and the first $15 million of the two-tranche round has been drawn down. The financing enables DFINE to make a greater investment in its launch of the Spinal Tumor Ablation with Radiofrequency (STAR™) System later this year and in early 2012. Emphasis will include the initiation of clinical studies necessary to build a body of evidence in favor of the treatment, and clinical marketing initiatives to support its commercial uptake. The company will also allocate funds for other pipeline projects and the continued expansion of its sales organization. “DFINE’s platform technology represents a generational advance over conventional therapies and provides physicians with tools to treat patients with enhanced precision and control,” said Josh Baltzell, managing director of Split Rock Partners. “We continue to be impressed with the company’s growth and believe in the strong product pipeline and strategic direction of the company.” “We are pleased to have the continued support of our current investors as we further demonstrate the clinical acceptance of our products and versatility of our platform in the marketplace,” said Kevin Mosher, chief executive officer of DFINE. “This financing enables us to continue to scale our business while enhancing profitability.” About DFINE DFINE is dedicated to relieving pain and improving the quality of life for patients suffering from vertebral pathologies through innovative, minimally invasive therapies. DFINE’s devices are built upon an extensible radiofrequency (RF) platform that presently covers two procedural applications. The first application, the StabiliT® Vertebral Augmentation System and StabiliT® ER2 Bone Cement, harnesses the power of radiofrequency energy to repair fractured vertebrae. The company has received FDA 510(k) clearance for a second application, the STAR™ Ablation System, for the palliative treatment of spinal tumors. The STAR system will be commercially available later this year. DFINE is based in San Jose, Calif. and is privately held. © 2015 Buyouts Insider / Argosy Group LLC

Vanguard Ventures Investments

189 Investments

Vanguard Ventures has made 189 investments. Their latest investment was in DFine as part of their Series F - II on November 11, 2011.

CBI Logo

Vanguard Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2011

Series F - II

DFine

$10M

No

1/17/2011

Series F

Vocera Communications

$6.3M

No

7/21/2010

Series E

DFine

$36.2M

No

3/11/2010

Debt

Subscribe to see more

$99M

Subscribe to see more

10

1/6/2010

Series G

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/8/2011

1/17/2011

7/21/2010

3/11/2010

1/6/2010

Round

Series F - II

Series F

Series E

Debt

Series G

Company

DFine

Vocera Communications

DFine

Subscribe to see more

Subscribe to see more

Amount

$10M

$6.3M

$36.2M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

Vanguard Ventures Portfolio Exits

50 Portfolio Exits

Vanguard Ventures has 50 portfolio exits. Their latest portfolio exit was DFine on July 06, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/6/2016

Acquired

$991

1

10/19/2015

Acquired

$991

2

3/15/2013

Acquired

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

7/6/2016

10/19/2015

3/15/2013

00/00/0000

00/00/0000

Exit

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Vanguard Ventures Fund History

8 Fund Histories

Vanguard Ventures has 8 funds, including Vanguard VII LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/21/2000

Vanguard VII LP

Early-Stage Venture Capital

$240M

1

6/30/1998

Vanguard VI LP

Subscribe to see more

$99M

10

12/31/1996

Vanguard V LP

Subscribe to see more

$99M

10

8/11/1992

Vanguard IV LP

Subscribe to see more

$99M

10

12/31/1989

Vanguard Associates III LP

Subscribe to see more

$99M

10

Closing Date

9/21/2000

6/30/1998

12/31/1996

8/11/1992

12/31/1989

Fund

Vanguard VII LP

Vanguard VI LP

Vanguard V LP

Vanguard IV LP

Vanguard Associates III LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$240M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Vanguard Ventures Team

13 Team Members

Vanguard Ventures has 13 team members, including current Managing Director, Daniel L. Eilers.

Name

Work History

Title

Status

Daniel L. Eilers

Managing Director

Current

Dr. Jack Gill

Managing Director

Current

Thomas C. Mcconnell

Managing Director

Current

Dr. Bob Ulrich

Managing Director

Current

Don Wood

Managing Director

Current

Name

Daniel L. Eilers

Dr. Jack Gill

Thomas C. Mcconnell

Dr. Bob Ulrich

Don Wood

Work History

Title

Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.